Shana Claeys

Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment

Irina Lambertz, Candy Kumps, Shana Claeys et al. · Clinical Cancer Research · 2015 · 80 citations · Full text

Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma

Kristina B. Emdal, Anna-Kathrine Pedersen, Dorte B. Bekker‐Jensen et al. · Science Signaling · 2018 · 43 citations · Full text

Cell Death, Insulin Receptor, Glioma +17

The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness

Liselot Mus, Irina Lambertz, Shana Claeys et al. · Scientific Reports · 2020 · 28 citations · Full text

ALK positively regulates MYCN activity through repression of HBP1 expression

Shana Claeys, Geertrui Denecker, Kaat Durinck et al. · Oncogene · 2018 · 25 citations · Full text

Transcriptional Regulation, Signal Transduction, Signaling Pathway +9

A high-throughput 3’ UTR reporter screening identifies microRNA interactomes of cancer genes

Gert Van Peer, Evelien Mets, Shana Claeys et al. · PLoS ONE · 2018 · 16 citations · Full text